![Mehis Pold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Mehis Pold joined CeMines, Inc. in September 2004 as a Director of Development.
He received an MD from Tartu University in 1988.
He has nearly 15 years of experience in cancer research as a Postdoctoral and Junior Faculty Member at UCLA, West Los Angeles VA Hospital and the Burnham Institute.
He became a Junior Faculty Member at Division of Pulmonary and Critical Care Medicine in 2000.
Ehemalige bekannte Positionen von Mehis Pold
Unternehmen | Position | Ende |
---|---|---|
CeMines, Inc.
![]() CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Ausbildung von Mehis Pold
University of Tartu | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CeMines, Inc.
![]() CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |